Published in J Eur Acad Dermatol Venereol on July 01, 2014
Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1. Int J Cancer (1999) 3.19
Phenotypic and genotypic characterization of antibiotic-resistant Propionibacterium acnes isolated from acne patients attending dermatology clinics in Europe, the U.S.A., Japan and Australia. Br J Dermatol (2001) 2.14
Induction of toll-like receptors by Propionibacterium acnes. Br J Dermatol (2005) 1.54
Prospective study of risk factors of relapse after treatment of acne with oral isotretinoin. Dermatology (2006) 1.44
European evidence-based (S3) guidelines for the treatment of acne. J Eur Acad Dermatol Venereol (2012) 1.40
[Treatment of seborrheic dermatitis]. Ann Dermatol Venereol (2004) 1.39
Rosacea - global diversity and optimized outcome: proposed international consensus from the Rosacea International Expert Group. J Eur Acad Dermatol Venereol (2010) 1.30
Childhood epileptic encephalopathy with diffuse slow spike-waves (otherwise known as "petit mal variant") or Lennox syndrome. Epilepsia (1966) 1.26
ECCA grading scale: an original validated acne scar grading scale for clinical practice in dermatology. Dermatology (2007) 1.20
Clinical variants of the preprotuberant stage of dermatofibrosarcoma protuberans. Br J Dermatol (2005) 1.19
Prevention and treatment of post-partum depression: a controlled randomized study on women at risk. Psychol Med (2002) 1.17
Modulation of integrins and filaggrin expression by Propionibacterium acnes extracts on keratinocytes. Arch Dermatol Res (2007) 0.99
Propranolol-resistant infantile haemangiomas. Br J Dermatol (2013) 0.97
High-scale expansion of melanoma-reactive TIL by a polyclonal stimulus: predictability and relation with disease advancement. Cancer Immunol Immunother (2001) 0.94
In vitro modulation of keratinocyte wound healing integrins by zinc, copper and manganese. Br J Dermatol (1999) 0.90
Semiology of skin toxicity associated with epidermal growth factor receptor (EGFR) inhibitors. Support Care Cancer (2012) 0.90
[Minocycline]. Ann Dermatol Venereol (2001) 0.88
Surgical repair of labial defect. Eur Ann Otorhinolaryngol Head Neck Dis (2010) 0.87
Loss of oncostatin M receptor beta in metastatic melanoma cells. Oncogene (2006) 0.86
Efficacy and safety of biologics in erythrodermic psoriasis: a multicentre, retrospective study. Br J Dermatol (2012) 0.85
[Cardiovascular manifestations associated with interferon alfa-2A]. Ann Med Interne (Paris) (1991) 0.83
Isotretinoin therapy and the incidence of acne relapse: a nested case-control study. Br J Dermatol (2008) 0.83
Modulatory effects of selenium and strontium salts on keratinocyte-derived inflammatory cytokines. Eur J Dermatol (2002) 0.83
Relationship between responsiveness of cancer cells to Oncostatin M and/or IL-6 and survival of stage III melanoma patients treated with tumour-infiltrating lymphocytes. J Pathol (2008) 0.83
Interleukin-15 expression in cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome). Br J Dermatol (2001) 0.83
Anti-inflammatory effects of lithium gluconate on keratinocytes: a possible explanation for efficiency in seborrhoeic dermatitis. Arch Dermatol Res (2008) 0.83
Onychopathy induced by temsirolimus, a mammalian target of rapamycin inhibitor. Dermatology (2012) 0.83
Melanoma and rituximab: an incidental association? Dermatology (2013) 0.82
Heredity: a prognostic factor for acne. Dermatology (2006) 0.82
In vitro modulation of epidermal inflammatory cytokines (IL-1 alpha, IL-6, TNF alpha) by minocycline. Arch Dermatol Res (1996) 0.82
[Epileptic encephalopathy of children with diffuse slow spikes and waves (alias "petit mal variant") or Lennox syndrome]. Ann Pediatr (Paris) (1966) 0.82
Comparison of three culture media for the establishment of melanoma cell lines. Cytotechnology (2010) 0.81
Computerized tomography in the study of West's syndrome. Dev Med Child Neurol (1978) 0.81
Interest of corrective makeup in the management of patients in dermatology. Clin Cosmet Investig Dermatol (2012) 0.80
Specificity of T cells invading the skin during acute graft-vs.-host disease after semiallogeneic bone marrow transplantation. J Clin Invest (1993) 0.80
Presence of Epstein-Barr virus in Langerhans cells of CTCL lesions. J Invest Dermatol (2005) 0.80
A tool to evaluate rapidly the quality of clinical trials on topical acne treatment. J Eur Acad Dermatol Venereol (2008) 0.80
Guidelines of the French Society of Otorhinolaryngology (SFORL), short version. Extension assessment and principles of resection in cutaneous head and neck tumors. Eur Ann Otorhinolaryngol Head Neck Dis (2014) 0.80
Incidence and characteristics of melanoma brain metastases developing during treatment with vemurafenib. J Neurooncol (2014) 0.80
Toll-like receptors 2, 4 and 9 expression in cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome). Eur J Dermatol (2007) 0.79
Prognostic factors in Sézary syndrome: a study of 28 patients. Br J Dermatol (2003) 0.79
Dramatic efficacy of brentuximab vedotin in two patients with epidermotropic cutaneous T-cell lymphomas after treatment failure despite variable CD30 expression. Br J Dermatol (2015) 0.79
[Detection, prevention and treatment of postpartum depression: a controlled study of 859 patients]. Encephale (2002) 0.79
Management of cutaneous adverse events induced by anti-EGFR (epidermal growth factor receptor): a French interdisciplinary therapeutic algorithm. Support Care Cancer (2012) 0.78
Prognostic value of tyrosinase reverse-transcriptase polymerase chain reaction in metastatic melanoma. Dermatology (2001) 0.78
Evaluation of a 1-h exposure time to mechlorethamine in patients undergoing topical treatment. Br J Dermatol (2002) 0.78
[Sarcoidosis granuloma on a tattoo induced by interferon alpha]. Ann Dermatol Venereol (2004) 0.78
Home therapy with autologous tumour-infiltrating lymphocytes and subcutaneous interleukin-2 in metastatic melanoma. Eur J Cancer (1996) 0.78
Survey on the management of skin toxicity associated with EGFR inhibitors amongst French physicians. J Eur Acad Dermatol Venereol (2012) 0.78
Evolution of clinical and molecular responses to bexarotene treatment in cutaneous T-cell lymphoma. Dermatology (2010) 0.78
Patients' profile, burden of disease and quality of life in recurrent herpes labialis: a survey conducted in USA and France. J Eur Acad Dermatol Venereol (2011) 0.78
Frequency of mucosal HPV DNA detection (types 6/11, 16/18, 31/35/51) in skin lesions of renal transplant patients. Transpl Int (1997) 0.78
Bacterial resistance in French acne patients. Int J Dermatol (2010) 0.77
A full GMP process to select and amplify epitope-specific T lymphocytes for adoptive immunotherapy of metastatic melanoma. Clin Dev Immunol (2013) 0.77
The benefit of chilling in argon-laser treatment of port-wine stains. Plast Reconstr Surg (1985) 0.77
Anti-inflammatory properties of a new undecyl-rhamnoside (APRC11) against P. acnes. Arch Dermatol Res (2011) 0.77
Long-term follow-up in 51 patients with mycosis fungoides and Sézary syndrome treated by interferon-alfa. Br J Dermatol (1999) 0.77
Usefulness of paraclinical follow-up in stage I melanoma. Arch Dermatol (1997) 0.77
Increased anti-Epstein-Barr virus antibodies in epidermotropic cutaneous T-cell lymphoma: a study of 64 patients. Br J Dermatol (1997) 0.77
The advantage of establishing homogeneous patient groups: is it worth isolating 'juvenile acne of the face'? J Eur Acad Dermatol Venereol (2008) 0.77
Management and outcome of metastatic melanoma during pregnancy. Br J Dermatol (2009) 0.76
Inter-observer agreement on acne severity based on facial photographs. J Eur Acad Dermatol Venereol (2009) 0.76
[Infliximab-induced hepatitis during treatment of vulvar Crohn's disease]. Ann Dermatol Venereol (2012) 0.76
Importance of spironolactone in the treatment of acne in adult women. J Eur Acad Dermatol Venereol (2010) 0.76
Toll-like receptor 2, 4, 7 and 9 expression in primary cutaneous CD30+ T-cell lymphoma. Br J Dermatol (2009) 0.76
Biclonal immunoglobulin M dysglobulinaemia: evolving aspects in a case of primary Sjögren's syndrome. Eur J Clin Chem Clin Biochem (1997) 0.76
Melanoma gene expression and clinical course. Arch Dermatol Res (2009) 0.76
Oral isotretinoin and pregnancy prevention programmes. Br J Dermatol (2012) 0.76
[Stenosing erosive lichen planus of the esophagus]. Gastroenterol Clin Biol (1983) 0.75
Differential effects of tert-butyl-benzohydroquinone, a putative SR Ca2+ pump inhibitor, on isometric relaxation during the staircase in the rabbit and rat ventricle. Br J Pharmacol (1996) 0.75
Circulating micrometastases following oncological surgery. Lancet (1996) 0.75
Innate immunity: a crucial target for zinc in the treatment of inflammatory dermatosis. J Eur Acad Dermatol Venereol (2011) 0.75
[Algorithm for treatment of juvenile facial acne]. Ann Dermatol Venereol (2010) 0.75
[Prolonged convulsive disease states of the child. Etiological, therapeutic and prognostic aspects (apropos of 100 cases)]. Pediatrie (1975) 0.75
[Lymphomatoid granulomatosis revealed by cutaneous lesions]. Ann Dermatol Venereol (2011) 0.75